Dr. Alex Addinsall has several years of medical research experience, having established a broad range of molecular, biochemical and in vivo animal physiology skills in the therapeutic areas of skeletal muscle physiology and metabolic disease.
In 2019, Dr. Addinsall was awarded his Ph.D. at the School of Medicine, Deakin University, Australia. Here, his studies established the importance of endoplasmic reticulum resident Selenoproteins to skeletal muscle health, metabolism and function, through characterization of Selenoprotein S.
Following the award of his Ph. D, Dr. Addinsall joined the Department of Physiology and Pharmacology at Karolinska Institutet, Sweden as a Swedish Research Council, Centrum För Idrottsforskning Postdoctoral Fellow. Here, under the the tutelage of Prof. Lars Larsson, Dr. Addinsall’s research explored the impact of critical care on skeletal muscle metabolic health. More specifically, he explored the mechanisms of action and the therapeutic potential of new physical and pharmacological therapies to counter ventilator induced myopathies including, Critical Illness Myopathy (CIM) and Ventilator Induced Diaphragm Dysfunction (VIDD).
Dr. Addinsall’s overall scientific interests are centred around gaining a greater appreciation of complex chronic conditions that limit patient quality of life. To this end, his research aims to contribute to the development of novel therapeutic initiatives to counter the debilitating disease pathophysiology, improve performance and restore healthy active lifestyles.
2019 – Doctor of Philosophy (Ph.D.) – Physiology
Deakin University, Geelong, Australia.
2015 – Bachelor of Health and Medical Science (Hons)
Deakin University, Geelong, Australia
2014- Bachelor of Health Science(s), Anatomy and Physiology
La Trobe University, Melbourne, Australia.